Thank you all for sharing your thoughts on yesterday's case.
This was a consult that came with a different question than the one that your answers appropriately brought up. The consulting pathologist's group disagreed on whether the clear cells were atypical or reactive in nature, and how to determine that with confidence.
The teaching points that can be gleaned from this case are the following:
1. Reactive change should not be used as a justification for cytologic atypia when a distinct subpopulation of atypical cells is identifiable. In this case, the cells with clear cytoplasm are atypical, pleomorphic, and form a distinct population that is both filling a duct and impinging on surrounding normal epithelium in a pagetoid pattern.
2. CK5/6 will sometimes show a mixed pattern of staining because of the admixture of the neoplastic cells with residual normal epithelium, and if the pathologist's bias is reactive, then it is easy to misinterpret this finding as evidence of a mixed population of cells, therefore excluding atypia/carcinoma.
3. Pagetoid patterns of spread can be seen with both ductal and lobular carcinoma in-situ, and when marked nuclear pleomorphism is present, I encourage you to ignore E-cadherin staining as it may result in under-diagnosis of a high-risk precursor lesion. In this case, E-cadherin was positive (no image available) but even if it were negative I would still call this ductal carcinoma in-situ to ensure the patient is treated appropriately.
So, my final interpretation of this case is Ductal carcinoma in-situ, nuclear grade 2/3 with clear cell change and pagetoid involvement of ducts.
- The below image exemplifies the concepts presented above, with a cohesive nodule of pleomorphic cells growing under the benign epithelium of a duct, which is sufficient for a diagnosis of ductal carcinoma in-situ in my humble opinion. Needless to say, if this was all there is on a biopsy, I would be conservative and call it atypical intraductal proliferation and wait for the excision.
@wusm_pathology
@washupathedu #breastpath #breastcancer #pathology #TwitterPath